Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADCY1 | Q08828 | 12/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | GMNN | O75496 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.60 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.60 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21779505 | 1.00 | ADCY1 (0.60) | ADCY1MAPK1CYP3A4TSHRSLC2A1 | |
| SCHEMBL11117898 | 1.00 | ADCY1 (0.60) | ADCY1MAPK1CYP3A4TSHRSLC2A1 | |
| SCHEMBL9870844 | 1.00 | ADCY1 (0.60) | ADCY1MAPK1CYP3A4TSHRSLC2A1 | |
| SCHEMBL10020759 | 1.00 | ADCY1 (0.60) | ADCY1MAPK1CYP3A4TSHRSLC2A1 | |
| SCHEMBL12028527 | 1.00 | ADCY1 (0.60) | ADCY1MAPK1CYP3A4TSHRSLC2A1 | |
| SCHEMBL13639992 | 1.00 | ADCY1 (0.60) | ADCY1MAPK1CYP3A4TSHRSLC2A1 | |
| SCHEMBL18601237 | 1.00 | ADCY1 (0.60) | ADCY1MAPK1CYP3A4TSHRSLC2A1 | |
| SCHEMBL31499204 | 0.92 | ADCY1 (0.55) | ADCY1MAPK1CYP3A4TSHRSLC2A1 | |
| SCHEMBL9591299 | 0.91 | ADCY1 (0.55) | ADCY1MAPK1CYP3A4TSHRSLC2A1 | |
| SCHEMBL10637035 | 0.91 | ADCY1 (0.55) | ADCY1MAPK1CYP3A4TSHRSLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0116713-A1 | Novel labdane derivatives, process for the preparation thereof, and pharmaceutical compositions containing labdane derivatives | SCHERING CORPORATION (US) | 1984-08-29 | — | — | EP | claimed |
| WO-2025087947-A1 | COSMETIC COMPOSITION FOR IMPROVING STRAND DENSITY OF THE HAIR | PEIGNE, Catherine (FR) | 2025-05-01 | — | — | WO | disclosed |
| EP-3687526-A1 | A COMPOSITION FOR USE IN THE PREVENTION AND/OR TREATMENT OF GLAUCOMA | Neilos S.r.l. (IT) | 2020-08-05 | — | — | EP | disclosed |
| WO-2019064245-A1 | A COMPOSITION FOR USE IN THE PREVENTION AND/OR TREATMENT OF GLAUCOMA | Neilos S.r.l. (IT) | 2019-04-04 | — | — | WO | disclosed |
| US-10240173-B2 | Biosynthesis of forskolin and related compounds | UNIVERSITY OF COPENHAGEN (DK) | 2019-03-26 | — | — | US | disclosed |
| US-20190010527-A1 | Biosynthesis of Forskolin and Related Compounds | DANSTAR FERMENT AG (CH) | 2019-01-10 | — | — | US | disclosed |
| US-10053717-B2 | Biosynthesis of forskolin and related compounds | UNIVERSITY OF COPENHAGEN (DK) | 2018-08-21 | — | — | US | disclosed |
| US-20180112243-A1 | BIOSYNTHESIS OF ACETYLATED 13R-MO AND RELATED COMPOUNDS | EVOLVA SA (CH) | 2018-04-26 | — | — | US | disclosed |
| EP-3283623-A1 | BIOSYNTHESIS OF ACETYLATED 13R-MO AND RELATED COMPOUNDS | Evolva SA (CH) | 2018-02-21 | — | — | EP | disclosed |
| WO-2018015512-A1 | BIOSYNTHESIS OF 13R-MANOYL OXIDE DERIVATIVES | EVOLVA SA (CH) | 2018-01-25 | — | — | WO | disclosed |
| US-4782082-A | BRONCHODILATORS, ANTIHISTAMINES | SCHERING CORPORATION (US) | 1988-11-01 | — | — | US | disclosed |
| US-4740522-A | Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1988-04-26 | — | — | US | disclosed |
| US-4734513-A | Method of synthesizing forskolin from 9-deoxyforskolin | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1988-03-29 | — | — | US | disclosed |
| US-4734513-A | Method of synthesizing forskolin from 9-deoxyforskolin | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1988-03-29 | — | — | US | disclosed |
| US-4734513-A | Method of synthesizing forskolin from 9-deoxyforskolin | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1988-03-29 | — | — | US | disclosed |
| EP-0257631-A2 | Oxolabdanes, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1988-03-02 | — | — | EP | disclosed |
| EP-0243646-A1 | A process for the preparation of forskolin from 9-deoxy-forskolin and intermediates used therein | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1987-11-04 | — | — | EP | disclosed |
| EP-0243646-A1 | A process for the preparation of forskolin from 9-deoxy-forskolin and intermediates used therein | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1987-11-04 | — | — | EP | disclosed |
| US-4517200-A | Method for treating allergic reactions with forskolin | SCHERING-PLOUGH CORPORATION (US) | 1985-05-14 | — | — | US | disclosed |
| EP-0116713-A1 | Novel labdane derivatives, process for the preparation thereof, and pharmaceutical compositions containing labdane derivatives | SCHERING CORPORATION (US) | 1984-08-29 | — | — | EP | disclosed |